Publikacje

Are compounds acting at metabotropic glutamate receptors the answer to treating depression? Agnieszka Palucha
Expert opinion on investigational drugs,
PMID:17107280
Niedziela, 19 Listopada 2006
Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety. Mariusz Papp, Ewa Litwa, Piotr Gruca, Elisabeth Mocaër
Behavioural pharmacology,
PMID:16377959
Piątek, 27 Października 2006
Effects of glycogen synthase kinase 3beta and cyclin-dependent kinase 5 inhibitors on morphine-induced analgesia and tolerance in rats. Jan Rodriguez Parkitna, Ilona Obara, Agnieszka Wawrzczak-Bargiela, Wioletta Makuch, Barbara Przewlocka, Ryszard Przewlocki
The Journal of pharmacology and experimental therapeutics,
PMID:16902054
Piątek, 20 Października 2006
Effect of antidepressant drugs in mice lacking the norepinephrine transporter. Marta Dziedzicka-Wasylewska, Agata Faron-Górecka, Maciej Kuśmider, Elzbieta Drozdowska, Zofia Rogóz, Joanna Siwanowicz, Marc G Caron, Heinz Bönisch
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
PMID:16554743
Środa, 18 Października 2006
Comparison of gene expression profiles in neuropathic and inflammatory pain. J Rodriguez Parkitna, M Korostynski, D Kaminska-Chowaniec, I Obara, J Mika, B Przewlocka, R Przewlocki
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,
PMID:17033093
Środa, 11 Października 2006
Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent. K Stachowicz, E Chojnacka-Wójcik, K Kłak, A Pilc
Neuropharmacology,
PMID:17020774
Wtorek, 3 Października 2006
Role of DNA polymerase IV in Escherichia coli SOS mutator activity. Wojciech Kuban, Magdalena Banach-Orlowska, Roel M Schaaper, Piotr Jonczyk, Iwona J Fijalkowska
Journal of bacteriology,
PMID:16980447
Piątek, 15 Września 2006
Preclinical and clinical pharmacology of DOV 216,303, a  Phil Skolnick, Philip Krieter, Joseph Tizzano, Anthony Basile, Piotr Popik, Pal Czobor, Arnold Lippa
CNS drug reviews,
PMID:16958986
Piątek, 8 Września 2006
Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease. K Ossowska, M Smiałowska, K Kuter, J Wierońska, B Zieba, J Wardas, P Nowak, J Dabrowska, A Bortel, I Biedka, G Schulze, H Rommelspacher
Neuroscience,
PMID:16797138
Poniedziałek, 21 Sierpnia 2006
Enhancement of antidepressant-like effects but not brain-derived neurotrophic factor mRNA expression by the novel N-methyl-D-aspartate receptor antagonist neramexane in mice. Tomasz Kos, Beata Legutko, Wojciech Danysz, Gary Samoriski, Piotr Popik
The Journal of pharmacology and experimental therapeutics,
PMID:16740621
Poniedziałek, 21 Sierpnia 2006